Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Digestive Diseases and Sciences|December 5, 2018
Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?Federico Piñero, Fernando Rubinstein, Sebastián Marciano, et al.
Medicina|October 11, 2022
[Epidemiology of patients with hepatocellular carcinoma in a University hospital]Francisco M Calderon Novoa, Esteban Masino, Lucas Caram, et al.
Annals of Hepatology|September 12, 2020
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American populationRommel Zambrano-Huailla, Laura Guedes, Jose Tadeu Stefano, et al.
Metabolomics : Official Journal of the Metabolomic Society|June 17, 2021
Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotypeFlavia Noelia Mazzini, Frank Cook, John Gounarides, et al.
Proteomics|July 31, 2023
Integrated analysis of the transcriptome and its interaction with the metabolome in metabolic associated fatty liver disease: Gut microbiome signatures, correlation networks, and effect of PNPLA3 genotypeMaría Florencia Mascardi, Flavia Noelia Mazzini, Bárbara Suárez, et al.
European Journal of Gastroenterology & Hepatology|March 7, 2018
Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from ArgentinaFederico Piñero, Sebastián Marciano, Nora Fernández, et al.
Annals of Hepatology|August 25, 2020
Outbreak of hepatitis A in a post-vaccination era: High rate of co-infection with sexually transmitted diseasesSebastián Marciano, Diego Arufe, Leila Haddad, et al.
Oncotarget|May 19, 2025
Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinomaLeonardo Gomes da Fonseca, Federico Piñero, Margarita Anders, et al.
Journal of Medical Virology|January 20, 2018
Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world studySebastián Marciano, Leila Haddad, María V Reggiardo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated CirrhosisFederico Piñero, Margarita Anders, Carla Bermudez, et al.
Pageof 10